Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles [PDF]
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process.
Corinne Sauer, Robert Sauer
core
The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016. [PDF]
J Pharm Policy Pract, 2020 Zartab S +4 more
europepmc +1 more source
Clinical Trials, Innovation and Approaches to Ambidexterity in Pharmaceutical Startup Companies [PDF]
, 2013 The author investigated how the clinical trial process affected innovation in phar- maceutical start-up firms. An inductive qualitative case study methodology was uti- lized to investigate 3 pharmaceutical start-up firms who were conducting late stage ...
Heikki, Sørum
core
Market Structure, R&D and Advertising in the Pharmaceutical Industry [PDF]
Recent developments in the literature on market structure have allowed the generation of a few key testable predictions from the theory of strategic behaviour. The seminal model considers one simple but general relationship, that between market structure
Catherine Matraves
core
Pharmaceutical research in Wilhelmine Germany: The case of E. Merck [PDF]
In this paper, we describe the emergence and evolution of pharmaceutical research at the German company E. Merck during the late 19th and early 20th century.
Carsten Burhop
core
Pharmaceutical Market(ing): Theory and Reality
Theory, Methodology, Practice, 2010 The pharmaceutical market represents one of the most dynamic and controversial markets. Its specific features are rooted in the specific nature of its products and in the complex interests of the main constituents of market demand.
Stevan Vasiljev, Darko Pantelic
doaj
India's product patent protection regime: Less or more of "pills for the poor"? [PDF]
The year 2005 marks the end of transition period for many developing countries with competent pharmaceutical sectors that competed in supplying generic versions of patented drugs to LDCs before, thereby inducing price competition and enhancing access to ...
Gehl Sampath, Padmashree
core
Pharmaceutical Marketing Management in India
Journal of Pharmacoeconomics and Pharmaceutical ManagementBackground: In order to identify key tactics and their gaps, the researcher self- designed questionnaire responses from 80 respondents (who either work at managing level in a pharmaceutical company or own their own firm) on Google through convenience sampling across several areas in India.
openaire +2 more sources
Cost-effectiveness analysis of enzyme replacement therapy (ERT) for treatment of infantile-onset Pompe disease (IOPD) in the Iranian pharmaceutical market. [PDF]
Intractable Rare Dis Res, 2020 Hashempour R +4 more
europepmc +1 more source
Pharmaceutical Distribution Market Channels in Poland
Contemporary Economics, 2009 Distribution on the pharmaceutical market in Poland is interesting and the most difficult sphere to manage. Numerous varied and specialized companies operating on the market cause that the processes of choosing middlemen in distribution channels are very
Agnieszka Woś
doaj